Craig A Clifford, DVM, MS, DACVIM (Oncology), talks about mast cell tumors, sharing a bit about cytological grading, treatment options, common misconceptions, and more What are some controversies or ...
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling. Nature Cancer , 2025; DOI: 10.1038/s43018-024-00882-2 Cite This Page : ...
Roles of inflammatory mediators released from mast cells/basophils in diseases such as chronic urticaria, atopic dermatitis, contact hypersensitivity, inflammatory bowel diseases, autoimmune diseases, ...
To address this gap, researchers analyzed gene expression within individual tumor cells. This study reports the molecular features and interactions of tumor and immune cells associated with two ...
Innate immune cells are white blood cells that mediate innate immunity and include basophils, dendritic cells, eosinophils, Langerhans cells, mast cells ... lung injury, cancer and even natural ...
2001). Mast cell sarcoma is rare. There is destructive growth of a local tumor consisting of poorly differentiated mast cells without systemic involvement. Mast cell sarcoma develops into a ...
Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...
In vivo, tumor-bearing mice that had the HIF1α-deleted in T cells did not respond to ICB therapy. The researchers then showed a way to overcome that resistance to ICB therapy.